Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Lannett Company, Inc.    LCI

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Lannett Company, Inc. : 03/12/2013 - Lannett To Present At 25th Annual Roth Conference March 18

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/12/2013 | 07:58pm CEST


Contacts: Roger Pondel PondelWilkinson Inc. (310) 279-5980

LANNETT TO PRESENT AT 25th ANNUAL ROTH CONFERENCE MARCH 18

Philadelphia, PA - March 12, 2013 - Lannett Company, Inc. (NYSE MKT: LCI) today announced that the company will present at the 25th Annual Roth Conference on Monday, March 18, 2013, at 9:30 a.m. PT ( 12:30 p.m. ET) at The Ritz-Carlton Hotel in Dana Point, California.
Management will provide an overview of the company that will be available to interested parties through a live, listen-only audio web broadcast via the Internet at www.lannett.com. Listeners are encouraged to visit the web site at least 15 minutes prior to the start of the scheduled presentation to register, download and install any necessary audio software. The presentation will be archived and accessible on the web site for at least 30 days.

About Lannett Company, Inc.:

Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. For more information, visit
the company's website at www.lannett.com.
# # #

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LANNETT COMPANY, INC.
08/09 LANNETT : Announces Preliminary Fiscal 2017 Fourth Quarter and Full Year Financi..
08/08 LANNETT : Announces Preliminary Fiscal 2017 Fourth-Quarter And Full-Year Financi..
08/01 LANNETT : To Present At The Canaccord Genuity 37th Annual Growth Conference On A..
07/19 LANNETT CO INC : Change in Directors or Principal Officers, Financial Statements..
07/18 LANNETT : Appoints Samuel H. Israel As General Counsel
07/17 LANNETT COMPANY, INC. : Corporate News Blog - Lannett Co. Receives Approval for ..
07/17 LANNETT : Appoints Samuel H. Israel As General Counsel
07/14 LANNETT : Receives Approval For Cyproheptadine Hydrochloride Syrup, 2 mg/5 mL
06/28 LANNETT COMPANY, INC. : Corporate News Blog - Lannett Receives Approval for Addi..
06/26 LANNETT : Receives Approval For Additional Dosage Strengths Of Hydrocodone Bitar..
More news
Financials ($)
Sales 2017 654 M
EBIT 2017 242 M
Net income 2017 10,2 M
Debt 2017 798 M
Yield 2017 -
P/E ratio 2017 417,33
P/E ratio 2018 12,65
EV / Sales 2017 2,11x
EV / Sales 2018 2,09x
Capitalization 583 M
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 26,2 $
Spread / Average Target 67%
EPS Revisions
Managers
NameTitle
Arthur P. Bedrosian Chief Executive Officer & Director
Jeffrey Farber Chairman
Martin P. Galvan CFO, Treasurer & Vice President-Finance
Robert Ehlinger Chief Information Officer & VP-logistics
Kristin A. Arnold Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
LANNETT COMPANY, INC.583
JOHNSON & JOHNSON15.12%355 979
NOVARTIS7.69%216 915
ROCHE HOLDING LTD.3.78%216 699
PFIZER0.59%194 554
MERCK AND COMPANY4.45%167 705